chlorambucil and vidarabine phosphate

chlorambucil has been researched along with vidarabine phosphate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appelbaum, FR; Chapman, RA; Elias, L; Godwin, JE; Grever, MR; Head, DR; Metz, EN; Stock-Novack, D; Weick, JK	1
Begleiter, A; Liliemark, JO; Plunkett, W; Reed, JC	1
Bosanquet, AG; Daniel, PT; Dörken, B; Hummel, M; Sturm, I	1

Reviews

1 review(s) available for chlorambucil and vidarabine phosphate

Article	Year
Why do drugs work in CLL? Leukemia & lymphoma, 1996, Volume: 22 Suppl 2 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Cladribine; Clinical Trials as Topic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine Phosphate	1996

Trials

1 trial(s) available for chlorambucil and vidarabine phosphate

Article	Year
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study. Leukemia, 1993, Volume: 7, Issue:3 Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Chlorambucil; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine Phosphate	1993

Article

Year

A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.

Leukemia, 1993, Volume: 7, Issue:3

Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Chlorambucil; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine Phosphate

1993

Other Studies

1 other study(ies) available for chlorambucil and vidarabine phosphate

Article	Year
In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis. BMC cancer, 2005, Aug-18, Volume: 5 Topics: Aged; Antineoplastic Agents; Apoptosis; Arginine; Chlorambucil; Codon; Cyclophosphamide; DNA Mutational Analysis; Doxorubicin; Drug Resistance, Neoplasm; Female; Gamma Rays; Gene Expression Regulation, Neoplastic; Genes, p53; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational; Prognosis; Proline; Vidarabine Phosphate; Vincristine	2005

Article

Year

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.

BMC cancer, 2005, Aug-18, Volume: 5

Topics: Aged; Antineoplastic Agents; Apoptosis; Arginine; Chlorambucil; Codon; Cyclophosphamide; DNA Mutational Analysis; Doxorubicin; Drug Resistance, Neoplasm; Female; Gamma Rays; Gene Expression Regulation, Neoplastic; Genes, p53; Homozygote; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Polymorphism, Single-Stranded Conformational; Prognosis; Proline; Vidarabine Phosphate; Vincristine

2005